Literature DB >> 8136740

Virus recovery from stools of patients undergoing bone marrow transplantation.

X Troussard1, F Bauduer, E Gallet, F Freymuth, P Boutard, J J Ballet, O Reman, M Leporrier.   

Abstract

Diarrhea in marrow transplant recipients is a frequent complication attributable to non-infectious events such as acute GVHD or infectious events such as viral gastroenteritis. Rotavirus and enteric adenovirus are the most frequent viral pathogens. To determine the frequency of these infections, we prospectively examined the stool specimens of 94 patients who underwent autologous BMT (34 cases) or allogeneic BMT (60 cases). Stool specimens were examined from patients twice weekly. Nineteen of the 94 patients were infected with viral pathogens. This study showed: (1) an incidence of viral gastroenteritis identical in autologous and allogeneic BMT (20%), (2) a persistent risk despite treatment in laminar air flow rooms, (3) a significant association with severe acute GVHD, and (4) a significant risk of multiple viral infections in autologous BMT recipients. Rotavirus and adenovirus are a cause of enteritis involvement in patients undergoing BMT and they may be underdiagnosed and confused with GVHD. Screening of stool specimens after BMT should be directed to prevention and treatment of these viral infections to decrease the morbidity and mortality associated with BMT.

Entities:  

Mesh:

Year:  1993        PMID: 8136740

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  Norovirus gastroenteritis successfully treated with nitazoxanide.

Authors:  Danish M Siddiq; Hoonmo L Koo; Javier A Adachi; George M Viola
Journal:  J Infect       Date:  2011-08-09       Impact factor: 6.072

2.  Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  E L Ford-Jones; S Calvin
Journal:  Can Commun Dis Rep       Date:  2010-11-30

3.  Investigation of a Rotavirus Gastroenteritis Outbreak among Immunosuppressed Patients in a Hospital Setting.

Authors:  Ken Sugata; Jennifer Hull; Houping Wang; Kimberly Foytich; Sung-Sil Moon; Yoshiyuki Takahashi; Seiji Kojima; Tetsushi Yoshikawa; Baoming Jiang
Journal:  J Immunol Tech Infect Dis       Date:  2017-01-14

4.  New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children.

Authors:  C Henke-Gendo; G Harste; B Juergens-Saathoff; F Mattner; H Deppe; A Heim
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

Review 5.  Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial.

Authors:  M Van der Wielen; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-20       Impact factor: 3.267

6.  Gastrointestinal adenovirus infections in a tertiary referral centre in Saudi Arabia.

Authors:  J Akhter; S M Qadri; S H Myint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

7.  Diarrheal Morbidity During Hematopoietic Cell Transplantation: The Diagnostic Yield of Stool Cultures.

Authors:  Tamar Berger; Odil Giladi; Dafna Yahav; Haim Ben-Zvi; Oren Pasvolsky; Liat Shargian-Alon; Ofir Wolach; Uri Rozovski; Pia Raanani; Moshe Yeshurun
Journal:  Infect Dis Ther       Date:  2021-03-04

8.  Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients.

Authors:  M G van Kraaij; A W Dekker; L F Verdonck; A M van Loon; J Vinjé; M P Koopmans; M Rozenberg-Arska
Journal:  Bone Marrow Transplant       Date:  2000-08       Impact factor: 5.483

Review 9.  The gastrointestinal frontier: IgA and viruses.

Authors:  Sarah E Blutt; Margaret E Conner
Journal:  Front Immunol       Date:  2013-11-28       Impact factor: 7.561

Review 10.  Rotavirus infection in adults.

Authors:  Evan J Anderson; Stephen G Weber
Journal:  Lancet Infect Dis       Date:  2004-02       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.